Blood Research Institute, Versiti, Milwaukee, Wisconsin, USA.
Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Am J Hematol. 2020 Jul;95(7):784-791. doi: 10.1002/ajh.25800. Epub 2020 Apr 15.
Whole blood donation rapidly removes approximately 10% of a donor's blood volume and stimulates substantial changes in iron metabolism and erythropoiesis. We sought to identify donors who benefit from iron supplementation, describe the nature of the benefit, and define the time course for recovery from donation. Blood samples were collected over 24 weeks following whole blood donation from 193 participants, with 96 participants randomized to 37.5 mg daily oral iron. Changes in total body, red blood cell (RBC), and storage iron, hepcidin, erythropoietin, and reticulocyte count were modeled using semiparametric curves in a mixed model. and the changes were compared among six groups defined by baseline ferritin (<12; 12-50; ≥50 ng/mL) and iron supplementation. The effect of oral iron on storage and RBC iron recovery was minimal in donors with baseline ferritin ≥50 ng/mL, but sizeable when ferritin was <50 ng/mL. Iron initially absorbed went to RBC and storage iron pools when ferritin was <12 ng/mL but went mostly to RBCs when ferritin was ≥12 ng/mL. Donors with ferritin ≥12 ng/mL had a "ripple" increase in reticulocytes ~100 days after donation indicating physiological responses occur months following donation. Thus, iron supplements markedly enhance recovery from whole blood donation in donors with ferritin <50 ng/mL. However, full recovery from donation requires over 100 days when taking iron. The findings also highlight the value of the study of blood donors for understanding human hemoglobin and iron metabolism and their usefulness for future studies as additional biomarkers are discovered.
全血捐献会迅速去除献血者约 10%的血液量,并刺激铁代谢和红细胞生成发生重大变化。我们试图确定哪些献血者从补铁中受益,描述受益的性质,并确定从献血中恢复的时间过程。在 193 名参与者全血捐献后的 24 周内采集了血液样本,其中 96 名参与者随机分为每天口服 37.5 毫克铁的治疗组。采用混合模型中的半参数曲线对全身、红细胞(RBC)和储存铁、hepcidin、红细胞生成素和网织红细胞计数的变化进行建模,并在 6 个根据基线铁蛋白(<12;12-50;≥50ng/mL)和补铁定义的组之间比较变化。在基线铁蛋白≥50ng/mL 的献血者中,口服铁对储存铁和 RBC 铁恢复的影响很小,但在铁蛋白<50ng/mL 时则相当大。当铁蛋白<12ng/mL 时,最初吸收的铁进入 RBC 和储存铁池,但当铁蛋白≥12ng/mL 时,大部分进入 RBC。铁蛋白≥12ng/mL 的献血者在捐献后约 100 天出现网织红细胞“涟漪”增加,表明捐献后数月内会发生生理反应。因此,铁补充剂可显著增强铁蛋白<50ng/mL 的献血者从全血捐献中恢复。然而,服用铁后需要超过 100 天才能完全恢复。这些发现还突出了研究献血者对理解人类血红蛋白和铁代谢的价值,以及随着更多生物标志物的发现,它们对未来研究的有用性。